StonvexLoading…
StonvexStonvexStonvexCore line items from INCR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | ILS 238.84M | ILS 355.55M | ILS 388.68M | ILS 219.68M |
Operating Income | ILS -67.21M | ILS -41.57M | ILS 50.63M | ILS 28.18M |
Net Income | ILS -72.79M | ILS -63.53M | ILS 43.75M | ILS 7.29M |
EPS (Diluted) | ILS -1.48 | ILS -1.36 | ILS 0.99 | ILS 0.11 |
Total Assets | ILS 762.57M | ILS 786.61M | ILS 958.01M | ILS 696.54M |
Total Liabilities | ILS 364.90M | ILS 329.55M | ILS 436.53M | ILS 227.13M |
Cash & Equivalents | ILS 78.32M | ILS 101.14M | ILS 232.59M | ILS 196.22M |
Free Cash Flow OCF − CapEx | ILS -71.30M | ILS -56.25M | ILS 31.52M | ILS 16.11M |
Shares Outstanding | 1.59M | Not available | 438.75K | 139.97K |